VarmX

Leiden, Netherlands · Founded 2016 · Acquired/Merged (Operating Subsidiary)

Manufacturer of therapeutic drugs designed to restore blood clotting in patients experiencing bleeding events. VarmX is based in Leiden, Netherlands and was founded in 2016. Its last known valuation is $505 million (Sep 2025). It has raised $103 million.

Last price · $/share
—
Implied valuation
$505.0M
Total raised
$102.5M
Last round
—
What is VarmX worth?
$505.0Mlast known valuation
Free account
More of VarmX with a free account
  • ·The complete investor list: 13 names
  • ·Watch VarmX: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

VarmX funding history

No rounds on record

No funding rounds for VarmX are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

VarmX valuation

VarmX's last known valuation is $505 million, from Sep 2025. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.

How VarmX's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For VarmX, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked about VarmX

What is VarmX worth?
VarmX's last known valuation is $505.0M.
How much has VarmX raised?
VarmX has raised $102.5M in total funding across its recorded rounds.